Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Citi
US Department of Justice
Johnson and Johnson
Farmers Insurance
UBS
Cantor Fitzgerald
Cerilliant
Fuji
Colorcon

Generated: December 12, 2017

DrugPatentWatch Database Preview

Guerbet Company Profile

« Back to Dashboard

What is the competitive landscape for GUERBET, and what generic and branded alternatives to GUERBET drugs are available?

GUERBET has four approved drugs.



Summary for Guerbet

US Patents:0
Tradenames:5
Ingredients:4
NDAs:4
Drug Master File Entries: 1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
GuerbetDOTAREMgadoterate meglumineSOLUTION;INTRAVENOUS204781-005Mar 31, 2017RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
GuerbetOXILAN-300ioxilanINJECTABLE;INJECTION020316-001Dec 21, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
GuerbetDOTAREMgadoterate meglumineSOLUTION;INTRAVENOUS204781-003Mar 20, 2013RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
GuerbetOXILAN-350ioxilanINJECTABLE;INJECTION020316-002Dec 21, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
GuerbetDOTAREMgadoterate meglumineSOLUTION;INTRAVENOUS204781-001Mar 20, 2013RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
GuerbetDOTAREMgadoterate meglumineSOLUTION;INTRAVENOUS204781-004Mar 20, 2013RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
GuerbetHEXABRIXioxaglate meglumine; ioxaglate sodiumINJECTABLE;INJECTION018905-002Jul 26, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
GuerbetDOTAREMgadoterate meglumineSOLUTION;INTRAVENOUS204781-001Mar 20, 2013RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
GuerbetLIPIODOLethiodized oilOIL;INTRALYMPHATIC, INTRAUTERINE009190-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
GuerbetDOTAREMgadoterate meglumineSOLUTION;INTRAVENOUS204781-002Mar 20, 2013RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Guerbet

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
GuerbetHEXABRIXioxaglate meglumine; ioxaglate sodiumINJECTABLE;INJECTION018905-002Jul 26, 1985► Subscribe► Subscribe
GuerbetOXILAN-350ioxilanINJECTABLE;INJECTION020316-002Dec 21, 1995► Subscribe► Subscribe
GuerbetHEXABRIXioxaglate meglumine; ioxaglate sodiumINJECTABLE;INJECTION018905-002Jul 26, 1985► Subscribe► Subscribe
GuerbetOXILAN-300ioxilanINJECTABLE;INJECTION020316-001Dec 21, 1995► Subscribe► Subscribe
GuerbetHEXABRIXioxaglate meglumine; ioxaglate sodiumINJECTABLE;INJECTION018905-002Jul 26, 1985► Subscribe► Subscribe
GuerbetHEXABRIXioxaglate meglumine; ioxaglate sodiumINJECTABLE;INJECTION018905-002Jul 26, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Fish and Richardson
Covington
Merck
Chinese Patent Office
Daiichi Sankyo
Cantor Fitzgerald
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot